| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT76 KRT75 KRT6C LORICRIN KRT77 KRTAP1-3 | 4.03e-25 | 43 | 32 | 12 | GO:0030280 |
| GeneOntologyMolecularFunction | structural molecule activity | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 KRTAP1-3 | 2.50e-11 | 891 | 32 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.89e-06 | 130 | 32 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 1.20e-03 | 32 | 32 | 2 | GO:0046875 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 2.83e-22 | 75 | 31 | 12 | GO:0045109 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 9.82e-21 | 99 | 31 | 12 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 1.11e-20 | 100 | 31 | 12 | GO:0045103 |
| GeneOntologyBiologicalProcess | keratinization | 4.31e-17 | 87 | 31 | 10 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT76 KRT75 KRT6C LORICRIN KRT77 | 2.06e-15 | 189 | 31 | 11 | GO:0030216 |
| GeneOntologyBiologicalProcess | skin development | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT76 KRT75 KRT6C LORICRIN KRT77 | 1.06e-13 | 373 | 31 | 12 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | KRT1 KRT2 KRT3 KRT6A KRT6B KRT10 KRT76 KRT75 KRT6C LORICRIN KRT77 | 1.84e-13 | 284 | 31 | 11 | GO:0009913 |
| GeneOntologyBiologicalProcess | epidermis development | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT76 KRT75 KRT6C LORICRIN KRT77 | 1.29e-12 | 461 | 31 | 12 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | GATA2 KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 | 6.91e-12 | 870 | 31 | 14 | GO:0030855 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 4.03e-10 | 957 | 31 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | epithelium development | GATA2 KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 | 6.81e-09 | 1469 | 31 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | peptide cross-linking | 7.15e-08 | 27 | 31 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | entry of bacterium into host cell | 7.82e-05 | 9 | 31 | 2 | GO:0035635 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 2.59e-04 | 16 | 31 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 2.93e-04 | 17 | 31 | 2 | GO:0003334 | |
| GeneOntologyCellularComponent | keratin filament | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 3.10e-27 | 97 | 33 | 15 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 2.21e-25 | 227 | 33 | 17 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 2.87e-24 | 263 | 33 | 17 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 3.10e-15 | 899 | 33 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 2.61e-13 | 1179 | 33 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 2.91e-13 | 1187 | 33 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | cornified envelope | 1.07e-09 | 69 | 33 | 6 | GO:0001533 | |
| HumanPheno | Palmoplantar hyperkeratosis | 4.82e-09 | 129 | 18 | 8 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 5.45e-09 | 131 | 18 | 8 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 5.79e-09 | 132 | 18 | 8 | HP:0007556 | |
| HumanPheno | Abnormality of the plantar skin of foot | 4.50e-08 | 171 | 18 | 8 | HP:0100872 | |
| HumanPheno | Palmoplantar keratoderma | 6.07e-08 | 114 | 18 | 7 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 6.45e-08 | 115 | 18 | 7 | HP:0008066 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 1.48e-07 | 4 | 18 | 3 | HP:0007475 | |
| HumanPheno | Hyperkeratosis | 5.00e-07 | 233 | 18 | 8 | HP:0000962 | |
| HumanPheno | Abnormal epidermal morphology | 5.22e-07 | 94 | 18 | 6 | HP:0011124 | |
| HumanPheno | Abnormality of keratinization | 7.13e-07 | 244 | 18 | 8 | HP:0001035 | |
| HumanPheno | Hypergranulosis | 7.68e-07 | 22 | 18 | 4 | HP:0025114 | |
| HumanPheno | Epidermal acanthosis | 8.55e-07 | 54 | 18 | 5 | HP:0025092 | |
| HumanPheno | Knuckle pad | 2.05e-06 | 8 | 18 | 3 | HP:0032541 | |
| HumanPheno | Regional abnormality of skin | 3.34e-06 | 541 | 18 | 10 | HP:0011356 | |
| HumanPheno | Abnormal skin morphology of the palm | 3.49e-06 | 413 | 18 | 9 | HP:0040211 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 4.19e-06 | 33 | 18 | 4 | HP:0007431 | |
| HumanPheno | Palmoplantar blistering | 6.01e-06 | 11 | 18 | 3 | HP:0007446 | |
| HumanPheno | Epidermal thickening | 1.97e-05 | 379 | 18 | 8 | HP:0011368 | |
| HumanPheno | Abnormal palm morphology | 2.39e-05 | 521 | 18 | 9 | HP:0100871 | |
| HumanPheno | Orthokeratosis | 4.07e-05 | 20 | 18 | 3 | HP:0040162 | |
| HumanPheno | Thickened skin | 5.04e-05 | 431 | 18 | 8 | HP:0001072 | |
| HumanPheno | Steatocystoma multiplex | 7.05e-05 | 4 | 18 | 2 | HP:0012035 | |
| HumanPheno | Eruptive vellus hair cyst | 7.05e-05 | 4 | 18 | 2 | HP:0025248 | |
| HumanPheno | Blistering by anatomical location | 9.16e-05 | 26 | 18 | 3 | HP:0033800 | |
| HumanPheno | White lesion of the oral mucosa | 1.15e-04 | 28 | 18 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 1.15e-04 | 28 | 18 | 3 | HP:0002745 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.17e-04 | 5 | 18 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.17e-04 | 5 | 18 | 2 | HP:0030268 | |
| HumanPheno | Onychogryposis | 1.28e-04 | 29 | 18 | 3 | HP:0001805 | |
| HumanPheno | Abnormality of skin adnexa physiology | 1.45e-04 | 249 | 18 | 6 | HP:0025276 | |
| HumanPheno | Abnormal sweat gland morphology | 1.84e-04 | 260 | 18 | 6 | HP:0000971 | |
| HumanPheno | Hyperhidrosis | 2.16e-04 | 167 | 18 | 5 | HP:0000975 | |
| HumanPheno | Onychogryposis of toenails | 2.45e-04 | 7 | 18 | 2 | HP:0008401 | |
| HumanPheno | Onychogryposis | 2.45e-04 | 7 | 18 | 2 | HP:0001819 | |
| HumanPheno | Onychogryposis of fingernail | 4.18e-04 | 9 | 18 | 2 | HP:0040036 | |
| HumanPheno | Scaling skin | 5.12e-04 | 46 | 18 | 3 | HP:0040189 | |
| HumanPheno | Conjunctival nodule | 6.37e-04 | 11 | 18 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 6.37e-04 | 11 | 18 | 2 | HP:0100780 | |
| HumanPheno | Epidermal hyperkeratosis | 6.37e-04 | 11 | 18 | 2 | HP:0007543 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 6.37e-04 | 11 | 18 | 2 | HP:0007447 | |
| HumanPheno | Amniotic constriction ring | 6.37e-04 | 11 | 18 | 2 | HP:0009775 | |
| HumanPheno | Angular cheilitis | 7.62e-04 | 12 | 18 | 2 | HP:0030318 | |
| HumanPheno | Abnormal fingernail morphology | 9.49e-04 | 230 | 18 | 5 | HP:0001231 | |
| HumanPheno | Abnormality of hand joint mobility | 9.62e-04 | 57 | 18 | 3 | HP:0006256 | |
| HumanPheno | Erythema | 1.02e-03 | 133 | 18 | 4 | HP:0010783 | |
| HumanPheno | Hypohidrosis or hyperhidrosis | 1.05e-03 | 235 | 18 | 5 | HP:0007550 | |
| HumanPheno | Palmoplantar hyperhidrosis | 1.05e-03 | 14 | 18 | 2 | HP:0007410 | |
| HumanPheno | Abnormal placental membrane morphology | 1.05e-03 | 14 | 18 | 2 | HP:0011409 | |
| HumanPheno | Ear pain | 1.21e-03 | 15 | 18 | 2 | HP:0030766 | |
| HumanPheno | Abnormal nail morphology | 1.23e-03 | 516 | 18 | 7 | HP:0001597 | |
| HumanPheno | Fingernail dysplasia | 1.37e-03 | 16 | 18 | 2 | HP:0100798 | |
| HumanPheno | Palmar hyperhidrosis | 1.37e-03 | 16 | 18 | 2 | HP:0006089 | |
| HumanPheno | Paronychia | 1.37e-03 | 16 | 18 | 2 | HP:0001818 | |
| HumanPheno | Ichthyosis | 1.38e-03 | 144 | 18 | 4 | HP:0008064 | |
| HumanPheno | Diaphyseal undertubulation | 1.55e-03 | 17 | 18 | 2 | HP:0005019 | |
| HumanPheno | Localized skin lesion | 1.66e-03 | 897 | 18 | 9 | HP:0011355 | |
| HumanPheno | Nail dystrophy | 1.85e-03 | 156 | 18 | 4 | HP:0008404 | |
| MousePheno | hyperpigmentation | 1.14e-09 | 28 | 25 | 5 | MP:0001188 | |
| MousePheno | abnormal skin pigmentation | 7.86e-09 | 87 | 25 | 6 | MP:0002095 | |
| MousePheno | abnormal epidermal layer morphology | 1.46e-08 | 271 | 25 | 8 | MP:0001216 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 9.67e-08 | 132 | 25 | 6 | MP:0001240 | |
| MousePheno | abnormal foot pad morphology | 1.16e-07 | 26 | 25 | 4 | MP:0000574 | |
| MousePheno | hyperkeratosis | 4.75e-07 | 90 | 25 | 5 | MP:0001242 | |
| MousePheno | abnormal tail pigmentation | 6.27e-07 | 39 | 25 | 4 | MP:0005174 | |
| MousePheno | abnormal skin coloration | 6.47e-07 | 182 | 25 | 6 | MP:0011239 | |
| MousePheno | acanthosis | 9.37e-07 | 43 | 25 | 4 | MP:0001874 | |
| MousePheno | increased tail pigmentation | 1.10e-06 | 12 | 25 | 3 | MP:0011276 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 1.13e-06 | 45 | 25 | 4 | MP:0009611 | |
| MousePheno | abnormal keratinocyte morphology | 2.37e-06 | 54 | 25 | 4 | MP:0002655 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 5.00e-06 | 65 | 25 | 4 | MP:0001236 | |
| MousePheno | pigmentation phenotype | 8.30e-06 | 624 | 25 | 8 | MP:0001186 | |
| MousePheno | abnormal skin physiology | 9.24e-06 | 288 | 25 | 6 | MP:0005501 | |
| MousePheno | blistering | 9.98e-06 | 24 | 25 | 3 | MP:0001208 | |
| MousePheno | abnormal foot pigmentation | 1.61e-05 | 28 | 25 | 3 | MP:0009379 | |
| MousePheno | abnormal skin morphology | AEBP2 KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT76 CBL LORICRIN ALK | 1.67e-05 | 1455 | 25 | 11 | MP:0002060 |
| MousePheno | abnormal filiform papillae morphology | 6.41e-05 | 7 | 25 | 2 | MP:0000763 | |
| MousePheno | hypergranulosis | 1.10e-04 | 9 | 25 | 2 | MP:0009600 | |
| MousePheno | scaly skin | 1.25e-04 | 55 | 25 | 3 | MP:0001192 | |
| MousePheno | increased ear pigmentation | 1.37e-04 | 10 | 25 | 2 | MP:0011278 | |
| MousePheno | abnormal skin appearance | 1.49e-04 | 473 | 25 | 6 | MP:0009931 | |
| MousePheno | impaired skin barrier function | 1.96e-04 | 64 | 25 | 3 | MP:0002796 | |
| MousePheno | thick epidermis stratum granulosum | 2.00e-04 | 12 | 25 | 2 | MP:0009599 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 2.56e-04 | 70 | 25 | 3 | MP:0001239 | |
| MousePheno | translucent skin | 3.18e-04 | 15 | 25 | 2 | MP:0001201 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 3.18e-04 | 15 | 25 | 2 | MP:0001233 | |
| MousePheno | increased foot pad pigmentation | 3.63e-04 | 16 | 25 | 2 | MP:0000575 | |
| MousePheno | increased foot pigmentation | 3.63e-04 | 16 | 25 | 2 | MP:0030051 | |
| MousePheno | thick epidermis | 3.79e-04 | 80 | 25 | 3 | MP:0001219 | |
| MousePheno | abnormal corneocyte morphology | 4.62e-04 | 18 | 25 | 2 | MP:0030605 | |
| MousePheno | abnormal autopod morphology | 5.52e-04 | 390 | 25 | 5 | MP:0000572 | |
| MousePheno | flaky skin | 6.32e-04 | 21 | 25 | 2 | MP:0001195 | |
| MousePheno | abnormal tail morphology | 6.41e-04 | 403 | 25 | 5 | MP:0002111 | |
| MousePheno | enlarged sebaceous gland | 7.59e-04 | 23 | 25 | 2 | MP:0000652 | |
| MousePheno | rough coat | 8.27e-04 | 24 | 25 | 2 | MP:0010179 | |
| MousePheno | skin inflammation | 8.40e-04 | 105 | 25 | 3 | MP:0004947 | |
| MousePheno | decreased skin tensile strength | 9.72e-04 | 26 | 25 | 2 | MP:0003089 | |
| MousePheno | abnormal ear pigmentation | 9.72e-04 | 26 | 25 | 2 | MP:0000015 | |
| MousePheno | abnormal outer ear skin morphology | 1.05e-03 | 27 | 25 | 2 | MP:0030530 | |
| MousePheno | increased keratinocyte proliferation | 1.05e-03 | 27 | 25 | 2 | MP:0009583 | |
| MousePheno | abnormal tongue epithelium morphology | 1.05e-03 | 27 | 25 | 2 | MP:0000764 | |
| MousePheno | limbs/digits/tail phenotype | 1.13e-03 | 1258 | 25 | 8 | MP:0005371 | |
| MousePheno | abnormal outer ear morphology | 1.21e-03 | 119 | 25 | 3 | MP:0002177 | |
| MousePheno | abnormal skin tensile strength | 1.47e-03 | 32 | 25 | 2 | MP:0005275 | |
| MousePheno | abnormal head skin morphology | 1.66e-03 | 34 | 25 | 2 | MP:0030529 | |
| MousePheno | decreased food intake | 1.81e-03 | 137 | 25 | 3 | MP:0011940 | |
| MousePheno | abnormal epidermis stratum basale morphology | 1.97e-03 | 37 | 25 | 2 | MP:0001231 | |
| MousePheno | abnormal coat appearance | 2.02e-03 | 774 | 25 | 6 | MP:0001510 | |
| MousePheno | neonatal lethality | 2.37e-03 | 799 | 25 | 6 | MP:0002058 | |
| MousePheno | abnormal keratinocyte proliferation | 2.41e-03 | 41 | 25 | 2 | MP:0009582 | |
| MousePheno | small testis | 2.76e-03 | 823 | 25 | 6 | MP:0001147 | |
| MousePheno | perinatal lethality | 2.91e-03 | 1130 | 25 | 7 | MP:0002081 | |
| MousePheno | abnormal coat/ hair morphology | 3.32e-03 | 854 | 25 | 6 | MP:0000367 | |
| MousePheno | small gonad | 3.96e-03 | 885 | 25 | 6 | MP:0001116 | |
| MousePheno | delayed wound healing | 4.00e-03 | 53 | 25 | 2 | MP:0002908 | |
| Domain | Intermediate_filament_CS | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 1.06e-24 | 63 | 33 | 13 | IPR018039 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 5.84e-24 | 71 | 33 | 13 | SM01391 |
| Domain | IF | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 7.12e-24 | 72 | 33 | 13 | PS00226 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 8.66e-24 | 73 | 33 | 13 | PF00038 |
| Domain | IF | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 1.53e-23 | 76 | 33 | 13 | IPR001664 |
| Domain | Keratin_2_head | 1.26e-22 | 24 | 33 | 10 | IPR032444 | |
| Domain | Keratin_2_head | 1.26e-22 | 24 | 33 | 10 | PF16208 | |
| Domain | Keratin_II | 3.40e-22 | 26 | 33 | 10 | IPR003054 | |
| Domain | Keratin_I | 6.43e-15 | 44 | 33 | 8 | IPR002957 | |
| Domain | Keratin_B2 | 7.06e-07 | 40 | 33 | 4 | PF01500 | |
| Domain | GrpE_coiled_coil | 1.09e-06 | 12 | 33 | 3 | IPR013805 | |
| Domain | KAP | 3.20e-06 | 58 | 33 | 4 | IPR002494 | |
| Domain | Prefoldin | 7.63e-06 | 72 | 33 | 4 | IPR009053 | |
| Domain | GATA | 3.13e-04 | 15 | 33 | 2 | PF00320 | |
| Domain | Znf_GATA | 3.13e-04 | 15 | 33 | 2 | IPR000679 | |
| Domain | GATA_ZN_FINGER_1 | 3.58e-04 | 16 | 33 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 3.58e-04 | 16 | 33 | 2 | PS50114 | |
| Domain | HR1_rho-bd | 8.85e-04 | 25 | 33 | 2 | IPR011072 | |
| Domain | - | 4.55e-03 | 57 | 33 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.70e-03 | 58 | 33 | 2 | IPR013088 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 3.44e-26 | 217 | 29 | 18 | M27640 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 | 9.67e-22 | 129 | 29 | 14 | M27649 |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-4 KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT77 KRTAP1-1 KRTAP1-3 | 1.16e-20 | 153 | 29 | 14 | MM15343 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT77 | 8.13e-18 | 87 | 29 | 11 | MM15351 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP5-4 KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT77 KRTAP1-1 KRTAP1-3 | 2.09e-13 | 502 | 29 | 14 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | GATA2 KRTAP5-4 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C LORICRIN KRT77 KRTAP1-4 KRTAP1-1 KRTAP1-3 | 8.90e-13 | 1432 | 29 | 19 | M509 |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 7.35e-05 | 40 | 29 | 3 | M48231 | |
| Pubmed | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 3.35e-28 | 63 | 33 | 13 | 16831889 | |
| Pubmed | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C KRT77 | 3.75e-26 | 57 | 33 | 12 | 31862882 | |
| Pubmed | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 1.10e-23 | 266 | 33 | 15 | 19380743 | |
| Pubmed | 2.27e-17 | 75 | 33 | 9 | 31527668 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 6.61e-17 | 84 | 33 | 9 | 29563501 | |
| Pubmed | 1.20e-16 | 24 | 33 | 7 | 27507811 | ||
| Pubmed | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT75 KRT6C HSPA2 KRT77 DDX3X | 3.10e-16 | 488 | 33 | 13 | 31324722 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 3.59e-15 | 16 | 33 | 6 | 12399393 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 2.11e-14 | 91 | 33 | 8 | 34445801 | |
| Pubmed | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C HSPA2 KRT77 DDX3X HNRNPA3 | 3.48e-14 | 1153 | 33 | 15 | 29845934 | |
| Pubmed | 6.00e-14 | 24 | 33 | 6 | 30719818 | ||
| Pubmed | 1.15e-13 | 59 | 33 | 7 | 26371508 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.25e-13 | 113 | 33 | 8 | 34474245 | |
| Pubmed | 1.31e-13 | 60 | 33 | 7 | 31220272 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT6C KRT77 DDX3X HNRNPA3 | 1.75e-13 | 605 | 33 | 12 | 28977666 |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP5-4 KRT1 KRT2 KRT3 KRT6B KRT8 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 2.82e-13 | 630 | 33 | 12 | 36949045 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT6C HSPA2 KRT77 | 2.60e-12 | 564 | 33 | 11 | 21565611 |
| Pubmed | 4.11e-12 | 46 | 33 | 6 | 36147463 | ||
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 6.45e-12 | 19 | 33 | 5 | 17002498 | |
| Pubmed | 6.45e-12 | 19 | 33 | 5 | 35173535 | ||
| Pubmed | 8.81e-12 | 191 | 33 | 8 | 33762435 | ||
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 1.13e-11 | 21 | 33 | 5 | 18824566 | |
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 1.13e-11 | 21 | 33 | 5 | 33029523 | |
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 1.13e-11 | 21 | 33 | 5 | 27287879 | |
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 1.13e-11 | 21 | 33 | 5 | 17373842 | |
| Pubmed | 1.13e-11 | 54 | 33 | 6 | 35474131 | ||
| Pubmed | 1.13e-11 | 197 | 33 | 8 | 23686814 | ||
| Pubmed | 1.38e-11 | 202 | 33 | 8 | 24639526 | ||
| Pubmed | High proliferation and delamination during skin epidermal stratification. | 1.46e-11 | 22 | 33 | 5 | 34050161 | |
| Pubmed | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C HSPA2 KRT77 HNRNPA3 | 1.63e-11 | 1442 | 33 | 14 | 35575683 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 2.54e-11 | 218 | 33 | 8 | 35831895 | |
| Pubmed | 2.67e-11 | 62 | 33 | 6 | 26644517 | ||
| Pubmed | 2.69e-11 | 346 | 33 | 9 | 25324306 | ||
| Pubmed | 3.58e-11 | 65 | 33 | 6 | 29795372 | ||
| Pubmed | 4.69e-11 | 8 | 33 | 4 | 7543090 | ||
| Pubmed | 4.69e-11 | 8 | 33 | 4 | 33294854 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 6.93e-11 | 558 | 33 | 10 | 27591049 | |
| Pubmed | 8.43e-11 | 9 | 33 | 4 | 17330888 | ||
| Pubmed | 8.43e-11 | 9 | 33 | 4 | 15737194 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 9.35e-11 | 31 | 33 | 5 | 37115925 | |
| Pubmed | 1.41e-10 | 417 | 33 | 9 | 19199708 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.17e-10 | 169 | 33 | 7 | 23084401 | |
| Pubmed | ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. | 3.31e-10 | 12 | 33 | 4 | 21127502 | |
| Pubmed | 4.77e-10 | 13 | 33 | 4 | 8999895 | ||
| Pubmed | 6.66e-10 | 45 | 33 | 5 | 30619335 | ||
| Pubmed | Lymphotoxin-beta regulates periderm differentiation during embryonic skin development. | 6.68e-10 | 14 | 33 | 4 | 17673451 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 17170733 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 29357356 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 17851587 | ||
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 7543104 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 7.78e-10 | 3 | 33 | 3 | 1713533 | |
| Pubmed | 7.78e-10 | 3 | 33 | 3 | 26581228 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GATAD1 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT77 DDX3X HNRNPA3 | 8.28e-10 | 1257 | 33 | 12 | 36526897 |
| Pubmed | 1.28e-09 | 51 | 33 | 5 | 36896912 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | KRT1 KRT2 KRT3 KRT6A KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C KRT77 | 2.31e-09 | 1070 | 33 | 11 | 23533145 |
| Pubmed | 2.33e-09 | 803 | 33 | 10 | 36517590 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 2.36e-09 | 238 | 33 | 7 | 35864588 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.53e-09 | 580 | 33 | 9 | 35676659 | |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 3.11e-09 | 135 | 33 | 6 | 29859926 | |
| Pubmed | Polymorphisms in the human high sulfur hair keratin-associated protein 1, KAP1, gene family. | 3.11e-09 | 4 | 33 | 3 | 12228244 | |
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 9054461 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 32179842 | ||
| Pubmed | 3.97e-09 | 21 | 33 | 4 | 22935613 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 5.42e-09 | 430 | 33 | 8 | 38172120 | |
| Pubmed | 6.26e-09 | 438 | 33 | 8 | 21630459 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 20301457 | ||
| Pubmed | 8.41e-09 | 286 | 33 | 7 | 32041737 | ||
| Pubmed | 9.03e-09 | 289 | 33 | 7 | 37132043 | ||
| Pubmed | 9.89e-09 | 26 | 33 | 4 | 15454262 | ||
| Pubmed | 1.12e-08 | 298 | 33 | 7 | 30737378 | ||
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 1.16e-08 | 27 | 33 | 4 | 27807348 | |
| Pubmed | 1.31e-08 | 305 | 33 | 7 | 33194618 | ||
| Pubmed | 1.52e-08 | 491 | 33 | 8 | 22623428 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 16790075 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 16239341 | ||
| Pubmed | 1.55e-08 | 6 | 33 | 3 | 7525178 | ||
| Pubmed | Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | 1.55e-08 | 6 | 33 | 3 | 14638864 | |
| Pubmed | 2.07e-08 | 31 | 33 | 4 | 20930145 | ||
| Pubmed | 2.07e-08 | 31 | 33 | 4 | 22274697 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 2.15e-08 | 328 | 33 | 7 | 23398456 | |
| Pubmed | 2.20e-08 | 329 | 33 | 7 | 35562734 | ||
| Pubmed | 2.25e-08 | 330 | 33 | 7 | 32529326 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 2.54e-08 | 336 | 33 | 7 | 31253590 | |
| Pubmed | Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation. | 2.72e-08 | 7 | 33 | 3 | 16837463 | |
| Pubmed | Regulation of epidermal differentiation by a Distal-less homeodomain gene. | 2.72e-08 | 7 | 33 | 3 | 8991098 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 3.56e-08 | 353 | 33 | 7 | 27545878 | |
| Pubmed | 3.95e-08 | 100 | 33 | 5 | 21800051 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT75 KRT6C DDX3X HNRNPA3 | 4.12e-08 | 1415 | 33 | 11 | 28515276 |
| Pubmed | 4.34e-08 | 37 | 33 | 4 | 17151017 | ||
| Pubmed | 4.34e-08 | 8 | 33 | 3 | 9932492 | ||
| Pubmed | Calmodulin 4 is dispensable for epidermal barrier formation and wound healing in mice. | 4.34e-08 | 8 | 33 | 3 | 25316000 | |
| Pubmed | 4.34e-08 | 8 | 33 | 3 | 15371305 | ||
| Pubmed | Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8. | 4.34e-08 | 8 | 33 | 3 | 24449888 | |
| Pubmed | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. | 5.99e-08 | 40 | 33 | 4 | 21151833 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 6.39e-08 | 224 | 33 | 6 | 28443643 | |
| Pubmed | 6.51e-08 | 9 | 33 | 3 | 16093647 | ||
| Pubmed | Aurora kinase-A deficiency during skin development impairs cell division and stratification. | 6.51e-08 | 9 | 33 | 3 | 22832491 | |
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 6.51e-08 | 9 | 33 | 3 | 16180309 | |
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 6.51e-08 | 9 | 33 | 3 | 19626033 | |
| Pubmed | 6.63e-08 | 41 | 33 | 4 | 34638806 | ||
| Interaction | KRT84 interactions | KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C CBL KRT77 | 2.16e-24 | 49 | 32 | 12 | int:KRT84 |
| Interaction | RNF208 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C KRT77 | 5.96e-22 | 75 | 32 | 12 | int:RNF208 |
| Interaction | KRT25 interactions | 3.80e-21 | 35 | 32 | 10 | int:KRT25 | |
| Interaction | KRT5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 1.37e-20 | 193 | 32 | 14 | int:KRT5 |
| Interaction | KRT6A interactions | KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 9.25e-20 | 160 | 32 | 13 | int:KRT6A |
| Interaction | KRT7 interactions | KRT1 KRT2 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 2.27e-19 | 80 | 32 | 11 | int:KRT7 |
| Interaction | KRT75 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 ANKS1A | 4.79e-19 | 181 | 32 | 13 | int:KRT75 |
| Interaction | KRT16 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 1.47e-18 | 197 | 32 | 13 | int:KRT16 |
| Interaction | PHTF1 interactions | 1.94e-18 | 20 | 32 | 8 | int:PHTF1 | |
| Interaction | DES interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 6.96e-18 | 158 | 32 | 12 | int:DES |
| Interaction | KRT12 interactions | 1.13e-17 | 24 | 32 | 8 | int:KRT12 | |
| Interaction | KRT36 interactions | 1.43e-17 | 74 | 32 | 10 | int:KRT36 | |
| Interaction | KRT17 interactions | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 3.77e-17 | 252 | 32 | 13 | int:KRT17 |
| Interaction | KRT14 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT76 KRT75 KRT6C CBL KRT77 DDX3X | 7.56e-17 | 192 | 32 | 12 | int:KRT14 |
| Interaction | KRT28 interactions | 8.92e-17 | 30 | 32 | 8 | int:KRT28 | |
| Interaction | PRPH interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 1.58e-16 | 204 | 32 | 12 | int:PRPH |
| Interaction | KRT26 interactions | 3.57e-16 | 35 | 32 | 8 | int:KRT26 | |
| Interaction | KRT20 interactions | 4.16e-16 | 63 | 32 | 9 | int:KRT20 | |
| Interaction | KRT18 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C CBL ALK KRT77 | 7.62e-16 | 419 | 32 | 14 | int:KRT18 |
| Interaction | KRT35 interactions | 9.90e-16 | 111 | 32 | 10 | int:KRT35 | |
| Interaction | KRT13 interactions | 1.56e-15 | 116 | 32 | 10 | int:KRT13 | |
| Interaction | KRT10 interactions | KRT1 KRT2 KRT6A KRT6B KRT8 KRT10 KRT76 KRT75 CBL KRT77 DDX3X | 3.56e-15 | 187 | 32 | 11 | int:KRT10 |
| Interaction | CRK interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 CBL KRT77 DDX3X | 5.54e-15 | 370 | 32 | 13 | int:CRK |
| Interaction | KRT19 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 | 7.85e-15 | 282 | 32 | 12 | int:KRT19 |
| Interaction | KRT33B interactions | 1.64e-14 | 93 | 32 | 9 | int:KRT33B | |
| Interaction | KRT8 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C HSPA2 KRT77 | 5.27e-14 | 441 | 32 | 13 | int:KRT8 |
| Interaction | ZUP1 interactions | 9.71e-14 | 174 | 32 | 10 | int:ZUP1 | |
| Interaction | KRT15 interactions | 1.22e-13 | 178 | 32 | 10 | int:KRT15 | |
| Interaction | VIM interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT10 KRT12 KRT76 KRT75 KRT6C CBL LORICRIN ALK KRT77 | 2.73e-13 | 804 | 32 | 15 | int:VIM |
| Interaction | KRT27 interactions | 4.36e-13 | 202 | 32 | 10 | int:KRT27 | |
| Interaction | HEXIM1 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C HSPA2 KRT77 DDX3X HNRNPA3 | 1.70e-12 | 913 | 32 | 15 | int:HEXIM1 |
| Interaction | KRT77 interactions | 1.89e-12 | 96 | 32 | 8 | int:KRT77 | |
| Interaction | KRT2 interactions | 2.06e-12 | 236 | 32 | 10 | int:KRT2 | |
| Interaction | KRT24 interactions | 2.12e-12 | 54 | 32 | 7 | int:KRT24 | |
| Interaction | KRT1 interactions | 2.24e-12 | 238 | 32 | 10 | int:KRT1 | |
| Interaction | CHD3 interactions | GATAD1 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT6C KRT77 DDX3X SP7 HNRNPA3 | 2.49e-12 | 757 | 32 | 14 | int:CHD3 |
| Interaction | KRT37 interactions | 2.63e-12 | 100 | 32 | 8 | int:KRT37 | |
| Interaction | EFNA1 interactions | 3.36e-12 | 103 | 32 | 8 | int:EFNA1 | |
| Interaction | KRT38 interactions | 4.61e-12 | 172 | 32 | 9 | int:KRT38 | |
| Interaction | EFNA3 interactions | 4.94e-12 | 108 | 32 | 8 | int:EFNA3 | |
| Interaction | CBL interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT6C CBL HSPA2 ALK SP7 | 9.91e-12 | 516 | 32 | 12 | int:CBL |
| Interaction | MEPCE interactions | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT76 KRT75 KRT6C HSPA2 KRT77 DDX3X HNRNPA3 | 1.36e-11 | 859 | 32 | 14 | int:MEPCE |
| Interaction | KRT6B interactions | 2.52e-11 | 132 | 32 | 8 | int:KRT6B | |
| Interaction | INPPL1 interactions | 3.29e-11 | 214 | 32 | 9 | int:INPPL1 | |
| Interaction | KRT31 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT76 KRT75 KRT6C KRT77 ANKS1A | 5.53e-11 | 453 | 32 | 11 | int:KRT31 |
| Interaction | KRT32 interactions | 6.60e-11 | 44 | 32 | 6 | int:KRT32 | |
| Interaction | UBASH3B interactions | 1.02e-10 | 157 | 32 | 8 | int:UBASH3B | |
| Interaction | SHC1 interactions | 1.40e-10 | 362 | 32 | 10 | int:SHC1 | |
| Interaction | KRT34 interactions | 3.95e-10 | 283 | 32 | 9 | int:KRT34 | |
| Interaction | KRT39 interactions | 4.14e-10 | 59 | 32 | 6 | int:KRT39 | |
| Interaction | LARP7 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT76 KRT75 KRT6C HSPA2 KRT77 DDX3X HNRNPA3 | 4.19e-10 | 1113 | 32 | 14 | int:LARP7 |
| Interaction | EIF3F interactions | 5.88e-10 | 296 | 32 | 9 | int:EIF3F | |
| Interaction | CUL5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT75 KRT77 DDX3X HNRNPA3 | 5.99e-10 | 567 | 32 | 11 | int:CUL5 |
| Interaction | KRT40 interactions | 8.17e-10 | 434 | 32 | 10 | int:KRT40 | |
| Interaction | MINDY4 interactions | 1.54e-09 | 73 | 32 | 6 | int:MINDY4 | |
| Interaction | TRAF6 interactions | 1.59e-09 | 465 | 32 | 10 | int:TRAF6 | |
| Interaction | PIK3R2 interactions | 2.12e-09 | 230 | 32 | 8 | int:PIK3R2 | |
| Interaction | KRT76 interactions | 3.63e-09 | 84 | 32 | 6 | int:KRT76 | |
| Interaction | IQCB1 interactions | 4.16e-09 | 370 | 32 | 9 | int:IQCB1 | |
| Interaction | CUL1 interactions | GATA2 KRT1 KRT2 KRT6A KRT6B KRT9 KRT10 KRT75 KRT6C DDX3X SP7 HNRNPA3 | 4.27e-09 | 876 | 32 | 12 | int:CUL1 |
| Interaction | KRT3 interactions | 4.82e-09 | 88 | 32 | 6 | int:KRT3 | |
| Interaction | LGR4 interactions | 5.89e-09 | 262 | 32 | 8 | int:LGR4 | |
| Interaction | DCUN1D1 interactions | 8.60e-09 | 275 | 32 | 8 | int:DCUN1D1 | |
| Interaction | AP2M1 interactions | 1.53e-08 | 430 | 32 | 9 | int:AP2M1 | |
| Interaction | CUL2 interactions | 1.57e-08 | 591 | 32 | 10 | int:CUL2 | |
| Interaction | CFTR interactions | KRT1 KRT2 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT75 KRT6C CBL HSPA2 KRT77 DDX3X | 1.67e-08 | 1480 | 32 | 14 | int:CFTR |
| Interaction | DIRAS2 interactions | 1.79e-08 | 52 | 32 | 5 | int:DIRAS2 | |
| Interaction | WTAP interactions | 1.89e-08 | 194 | 32 | 7 | int:WTAP | |
| Interaction | TRIM54 interactions | 2.86e-08 | 321 | 32 | 8 | int:TRIM54 | |
| Interaction | FGD5 interactions | 2.95e-08 | 207 | 32 | 7 | int:FGD5 | |
| Interaction | TNF interactions | 4.47e-08 | 340 | 32 | 8 | int:TNF | |
| Interaction | EPS15 interactions | 4.48e-08 | 220 | 32 | 7 | int:EPS15 | |
| Interaction | CYLD interactions | 4.99e-08 | 868 | 32 | 11 | int:CYLD | |
| Interaction | COPS5 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT76 KRT75 KRT6C DDX3X HNRNPA3 | 5.49e-08 | 1102 | 32 | 12 | int:COPS5 |
| Interaction | PIGR interactions | 5.81e-08 | 133 | 32 | 6 | int:PIGR | |
| Interaction | MYCN interactions | GATA2 KRT1 KRT2 ZC3H10 KRT6A KRT9 KRT10 HSPA2 LORICRIN KRT77 DDX3X SP7 HNRNPA3 | 6.58e-08 | 1373 | 32 | 13 | int:MYCN |
| Interaction | NPHP4 interactions | 7.25e-08 | 236 | 32 | 7 | int:NPHP4 | |
| Interaction | EFNA4 interactions | 7.90e-08 | 239 | 32 | 7 | int:EFNA4 | |
| Interaction | CHD4 interactions | KRT1 KRT2 KRT3 KRT6A KRT6B KRT9 KRT10 KRT6C KRT77 DDX3X HNRNPA3 | 1.10e-07 | 938 | 32 | 11 | int:CHD4 |
| Interaction | KIFC3 interactions | 1.13e-07 | 252 | 32 | 7 | int:KIFC3 | |
| Interaction | KRT6C interactions | 1.24e-07 | 76 | 32 | 5 | int:KRT6C | |
| Interaction | NEDD8 interactions | 1.36e-07 | 393 | 32 | 8 | int:NEDD8 | |
| Interaction | METTL14 interactions | 1.42e-07 | 558 | 32 | 9 | int:METTL14 | |
| Interaction | AHI1 interactions | 1.94e-07 | 83 | 32 | 5 | int:AHI1 | |
| Interaction | NUP62 interactions | 1.95e-07 | 273 | 32 | 7 | int:NUP62 | |
| Interaction | PRPF8 interactions | 2.02e-07 | 776 | 32 | 10 | int:PRPF8 | |
| Interaction | RNF8 interactions | 2.30e-07 | 421 | 32 | 8 | int:RNF8 | |
| Interaction | DDX24 interactions | 2.49e-07 | 596 | 32 | 9 | int:DDX24 | |
| Interaction | METTL3 interactions | 2.74e-07 | 287 | 32 | 7 | int:METTL3 | |
| Interaction | QSER1 interactions | 4.92e-07 | 100 | 32 | 5 | int:QSER1 | |
| Interaction | ARIH2 interactions | 5.02e-07 | 314 | 32 | 7 | int:ARIH2 | |
| Interaction | NPHP3 interactions | 5.62e-07 | 42 | 32 | 4 | int:NPHP3 | |
| Interaction | AAR2 interactions | 5.64e-07 | 657 | 32 | 9 | int:AAR2 | |
| Interaction | FBXL4 interactions | 6.58e-07 | 106 | 32 | 5 | int:FBXL4 | |
| Interaction | CAND1 interactions | 7.43e-07 | 894 | 32 | 10 | int:CAND1 | |
| Interaction | FAF1 interactions | 7.60e-07 | 334 | 32 | 7 | int:FAF1 | |
| Interaction | DCTN1 interactions | 8.08e-07 | 497 | 32 | 8 | int:DCTN1 | |
| Interaction | EIF4A3 interactions | 8.33e-07 | 499 | 32 | 8 | int:EIF4A3 | |
| Interaction | PTMA interactions | 9.11e-07 | 212 | 32 | 6 | int:PTMA | |
| Interaction | FBP1 interactions | 1.00e-06 | 348 | 32 | 7 | int:FBP1 | |
| Cytoband | 12q13.13 | 6.43e-19 | 67 | 33 | 9 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | KRT1 KRT2 ZC3H10 KRT3 KRT6A KRT6B KRT8 KRT76 KRT75 KRT6C KRT77 SP7 | 9.55e-17 | 423 | 33 | 12 | chr12q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.01e-06 | 473 | 33 | 6 | chr17q21 | |
| Cytoband | 12q13 | 1.21e-03 | 71 | 33 | 2 | 12q13 | |
| Cytoband | 17q12 | 2.33e-03 | 99 | 33 | 2 | 17q12 | |
| GeneFamily | Keratins, type II | 5.21e-22 | 27 | 32 | 10 | 609 | |
| GeneFamily | Keratins, type I | 1.60e-05 | 28 | 32 | 3 | 608 | |
| GeneFamily | Keratin associated proteins | 3.95e-05 | 109 | 32 | 4 | 619 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.14e-04 | 15 | 32 | 2 | 82 | |
| Coexpression | GU_PDEF_TARGETS_DN | 9.17e-12 | 40 | 33 | 6 | M10480 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 3.69e-11 | 173 | 33 | 8 | M650 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 5.62e-09 | 204 | 33 | 7 | MM966 | |
| Coexpression | JAEGER_METASTASIS_DN | 1.75e-05 | 260 | 33 | 5 | M10702 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 4.28e-05 | 8 | 33 | 2 | M19218 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 8.24e-05 | 67 | 33 | 3 | M40299 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 1.13e-04 | 200 | 33 | 4 | M5172 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.19e-04 | 13 | 33 | 2 | MM743 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 1.22e-04 | 204 | 33 | 4 | MM17090 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 1.60e-04 | 15 | 33 | 2 | M13308 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 3.00e-08 | 25 | 28 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | skin | 1.61e-06 | 456 | 28 | 7 | skin | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 3.23e-06 | 78 | 28 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 4.34e-06 | 84 | 28 | 4 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 6.23e-06 | 800 | 28 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 1.63e-05 | 426 | 28 | 6 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_500 | 1.73e-05 | 119 | 28 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.75e-05 | 276 | 28 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 6.35e-05 | 59 | 28 | 3 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 1.61e-04 | 401 | 28 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 2.15e-04 | 427 | 28 | 5 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.23e-04 | 90 | 28 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k4 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 2.30e-04 | 987 | 28 | 7 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.38e-04 | 92 | 28 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 2.87e-04 | 98 | 28 | 3 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 2.87e-04 | 98 | 28 | 3 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | esophagus | 2.94e-04 | 247 | 28 | 4 | esophagus | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.52e-04 | 105 | 28 | 3 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | 4.54e-04 | 780 | 28 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K4 | 5.11e-04 | 286 | 28 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.20e-04 | 120 | 28 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 5.37e-04 | 805 | 28 | 6 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.59e-04 | 123 | 28 | 3 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_100 | 7.61e-04 | 31 | 28 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 1.38e-03 | 168 | 28 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.71e-03 | 181 | 28 | 3 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_500 | 1.75e-03 | 47 | 28 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 1.75e-03 | 47 | 28 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 1.87e-03 | 406 | 28 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.89e-03 | 407 | 28 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_200 | 2.08e-03 | 194 | 28 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_200 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.35e-11 | 190 | 33 | 7 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.35e-11 | 190 | 33 | 7 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.35e-11 | 190 | 33 | 7 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.80e-09 | 187 | 33 | 6 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.36e-09 | 196 | 33 | 6 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.55e-09 | 197 | 33 | 6 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.41e-08 | 146 | 33 | 5 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.68e-07 | 172 | 33 | 5 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 186 | 33 | 5 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.29e-07 | 197 | 33 | 5 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-07 | 198 | 33 | 5 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.68e-06 | 117 | 33 | 4 | e13c50260d81e8f2ea99e5c680c9699da246067b | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-06 | 130 | 33 | 4 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.05e-06 | 136 | 33 | 4 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.40e-06 | 157 | 33 | 4 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 167 | 33 | 4 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.10e-06 | 174 | 33 | 4 | aceca0a22bb1e380835e792681cfc9b752fb5496 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-06 | 175 | 33 | 4 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-06 | 175 | 33 | 4 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 184 | 33 | 4 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 184 | 33 | 4 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 192 | 33 | 4 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 192 | 33 | 4 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 196 | 33 | 4 | 279f43deeba4528cd63f5217a8441b5452bf0b16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 197 | 33 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 197 | 33 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 197 | 33 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-05 | 197 | 33 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 198 | 33 | 4 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 198 | 33 | 4 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 198 | 33 | 4 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-05 | 200 | 33 | 4 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-05 | 200 | 33 | 4 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.40e-05 | 200 | 33 | 4 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.40e-05 | 200 | 33 | 4 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.40e-05 | 200 | 33 | 4 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 97 | 33 | 3 | 1da964954a95c497ac4a24df1ea3575df5747025 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 97 | 33 | 3 | dd188763ba02337e4f25d56766eda886cffa810d | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 97 | 33 | 3 | a0242258aad0766450ff52fe28278cbb2b8d63a0 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.06e-05 | 97 | 33 | 3 | 98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 122 | 33 | 3 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 122 | 33 | 3 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 125 | 33 | 3 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 131 | 33 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 139 | 33 | 3 | da8874d441b8e69c94bad771635f378ddafb49fe | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.63e-04 | 144 | 33 | 3 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 149 | 33 | 3 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 155 | 33 | 3 | cc3fc379ea78742a216317054f336331f7c7a157 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 155 | 33 | 3 | 1900a76754e2a9c7117e531c5907b7942f72c4a6 | |
| ToppCell | facs-MAT-Fat-24m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 156 | 33 | 3 | 7433c6d4eb4d061844d8979c1e648d8ed56e1073 | |
| ToppCell | facs-MAT-Fat-24m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 157 | 33 | 3 | a47d102570e82d34ea1a8756f82636e7ab27c07f | |
| ToppCell | facs-MAT-Fat-24m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 157 | 33 | 3 | 30814ff90cead688ef64dac4cf4a6d63756d8944 | |
| ToppCell | facs-MAT-Fat-24m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 157 | 33 | 3 | 7c20f225b2db8b340f4fec050ff29e666b860f04 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.19e-04 | 159 | 33 | 3 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 161 | 33 | 3 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 161 | 33 | 3 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 163 | 33 | 3 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 163 | 33 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.39e-04 | 164 | 33 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.39e-04 | 164 | 33 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 168 | 33 | 3 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 170 | 33 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 170 | 33 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 170 | 33 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.71e-04 | 171 | 33 | 3 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 172 | 33 | 3 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.75e-04 | 172 | 33 | 3 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-04 | 172 | 33 | 3 | 0f2771e1e24fd2235ceb96663f0513b4dd6552d1 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Basal|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.80e-04 | 173 | 33 | 3 | 3d3afc9ab234eaabf5b9bff455406231cd54ded6 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 173 | 33 | 3 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 2.80e-04 | 173 | 33 | 3 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.99e-04 | 177 | 33 | 3 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 179 | 33 | 3 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-04 | 182 | 33 | 3 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 184 | 33 | 3 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.35e-04 | 184 | 33 | 3 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.46e-04 | 186 | 33 | 3 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 187 | 33 | 3 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | facs-Trachea-nan-18m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 8882a638af7165b2910ba8e932d55475d7bfb003 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 188 | 33 | 3 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 188 | 33 | 3 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 3.63e-04 | 189 | 33 | 3 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.63e-04 | 189 | 33 | 3 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.63e-04 | 189 | 33 | 3 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-04 | 191 | 33 | 3 | cd4e2e883c4955fb2d875e41bb6ebc680994dc8c | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 02f24202f9fdd46c648265a5b3b6f9066aa009fc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 192 | 33 | 3 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| Computational | Keratin. | 4.62e-10 | 26 | 18 | 5 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 4.62e-10 | 26 | 18 | 5 | MODULE_68 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.45e-08 | 50 | 18 | 5 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Intermediate filaments and MT. | 4.19e-06 | 68 | 18 | 4 | MODULE_438 | |
| Computational | Genes in the cancer module 153. | 2.28e-05 | 34 | 18 | 3 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.36e-05 | 50 | 18 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes in the cancer module 111. | 1.03e-04 | 153 | 18 | 4 | MODULE_111 | |
| Computational | Developmental processes. | 1.70e-04 | 333 | 18 | 5 | MODULE_220 | |
| Computational | Genes in the cancer module 297. | 2.99e-04 | 80 | 18 | 3 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 2.99e-04 | 80 | 18 | 3 | MODULE_357 | |
| Computational | Genes in the cancer module 104. | 2.43e-03 | 353 | 18 | 4 | MODULE_104 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Neighborhood of ITGA2 | 3.87e-03 | 56 | 18 | 2 | MORF_ITGA2 | |
| Computational | Genes in the cancer module 322. | 4.28e-03 | 59 | 18 | 2 | MODULE_322 | |
| Computational | Genes in the cancer module 342. | 5.03e-03 | 213 | 18 | 3 | MODULE_342 | |
| Computational | Neighborhood of MYL3 | 5.98e-03 | 70 | 18 | 2 | MORF_MYL3 | |
| Drug | teleocidin B | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 3.85e-26 | 123 | 33 | 15 | CID000072425 |
| Drug | sulfur mustard | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 9.23e-26 | 130 | 33 | 15 | CID000010461 |
| Drug | homocysteine thiolactone | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 1.04e-25 | 131 | 33 | 15 | CID000107712 |
| Drug | al-Badry | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 3.86e-24 | 165 | 33 | 15 | CID000004545 |
| Drug | Velcade (bortezomib | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 1.03e-18 | 374 | 33 | 15 | CID000093860 |
| Drug | butyrate | GATA2 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C HSPA2 KRT77 KRTAP1-1 KRTAP1-3 SP7 | 1.66e-18 | 767 | 33 | 18 | CID000000264 |
| Drug | AC1L9MJT | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT75 KRT6C KRT77 | 2.78e-17 | 192 | 33 | 12 | CID000448959 |
| Drug | 1-2q | KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT75 KRT6C KRT77 | 3.90e-15 | 289 | 33 | 12 | CID000011820 |
| Drug | adenosine 3',5'-cyclic phosphate | GATA2 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 | 2.18e-14 | 907 | 33 | 16 | CID000000274 |
| Drug | SC-791 | 2.79e-14 | 6 | 33 | 5 | CID010291510 | |
| Drug | dithranol | 1.05e-13 | 18 | 33 | 6 | CID000002202 | |
| Drug | bromovanin | 1.35e-13 | 127 | 33 | 9 | ctd:C515564 | |
| Drug | ethylnylestradiol | KRT1 SHOX KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C KRT77 KRTAP1-1 KRTAP1-3 SP7 | 1.72e-13 | 1251 | 33 | 17 | CID000003285 |
| Drug | phorbol acetate myristate | GATA2 KRT1 KRT2 KRT3 KRT6A KRT6B KRT8 KRT9 KRT10 KRT12 KRT76 KRT75 KRT6C HSPA2 KRT77 KRTAP1-1 KRTAP1-3 | 1.05e-12 | 1399 | 33 | 17 | CID000004792 |
| Drug | clobestasol propionate | 2.85e-11 | 17 | 33 | 5 | CID000002791 | |
| Drug | Olux | 7.11e-11 | 20 | 33 | 5 | CID000032797 | |
| Drug | cignolin | 1.77e-10 | 56 | 33 | 6 | CID000010187 | |
| Drug | betamethasone valerate | 4.47e-10 | 28 | 33 | 5 | CID000016533 | |
| Drug | chrysarobin | 1.96e-09 | 37 | 33 | 5 | CID000068111 | |
| Drug | K-11 | 8.59e-09 | 17 | 33 | 4 | CID000469667 | |
| Drug | PD153035 | 2.62e-08 | 127 | 33 | 6 | CID000004705 | |
| Drug | MK-6 | 3.81e-08 | 24 | 33 | 4 | CID005283547 | |
| Drug | Bhg-(2-1)fuc | 4.53e-08 | 25 | 33 | 4 | CID005287784 | |
| Drug | Divonex | 4.90e-08 | 69 | 33 | 5 | CID000002522 | |
| Drug | NSC134723 | 5.53e-08 | 6 | 33 | 3 | CID000281830 | |
| Drug | phenyl isocyanate | 5.53e-08 | 6 | 33 | 3 | ctd:C025319 | |
| Drug | 1,4-pentanediamine | 7.48e-08 | 75 | 33 | 5 | CID000550880 | |
| Drug | 2-Formyl-Protoporphryn Ix | 1.12e-07 | 31 | 33 | 4 | CID011963946 | |
| Drug | AGN 193109 | 1.12e-07 | 31 | 33 | 4 | CID000177238 | |
| Drug | plakin | 1.17e-07 | 82 | 33 | 5 | CID000018752 | |
| Drug | Chromates | 2.32e-07 | 9 | 33 | 3 | ctd:D002840 | |
| Drug | CaLam | 2.90e-07 | 39 | 33 | 4 | CID004126474 | |
| Drug | AC1L1JLU | 3.87e-07 | 104 | 33 | 5 | CID000005098 | |
| Drug | 4-oxoretinoic acid | 6.38e-07 | 115 | 33 | 5 | ctd:C002202 | |
| Drug | rafoxanide | 7.86e-07 | 13 | 33 | 3 | CID000031475 | |
| Drug | mant-GTP | 8.03e-07 | 50 | 33 | 4 | CID000128647 | |
| Drug | CD-III | 1.02e-06 | 53 | 33 | 4 | CID000066693 | |
| Drug | N1-acetylspermidine | 3.11e-06 | 20 | 33 | 3 | CID000000496 | |
| Drug | 4-oxoretinoic acid | 4.59e-06 | 77 | 33 | 4 | CID006437063 | |
| Drug | AC1L1KPQ | 4.84e-06 | 78 | 33 | 4 | CID000005602 | |
| Drug | 4-hydroxytestosterone | 4.84e-06 | 78 | 33 | 4 | CID000160615 | |
| Drug | beta-damascenone | 5.50e-06 | 24 | 33 | 3 | ctd:C075388 | |
| Drug | monomethyl phthalate | 6.11e-06 | 957 | 33 | 9 | ctd:C517284 | |
| Drug | AC1L9LMC | 6.20e-06 | 83 | 33 | 4 | CID000448113 | |
| Drug | dimethyl phthalate | 6.23e-06 | 714 | 33 | 8 | ctd:C024629 | |
| Drug | olomoucine II | 7.92e-06 | 27 | 33 | 3 | CID005494414 | |
| Drug | Bi-E | 7.92e-06 | 27 | 33 | 3 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 8.87e-06 | 28 | 33 | 3 | CID011650719 | |
| Drug | CH2Cl | 8.87e-06 | 28 | 33 | 3 | CID005378701 | |
| Drug | sodium dodecyl sulfate | 8.94e-06 | 91 | 33 | 4 | CID000008778 | |
| Drug | K-13 | 1.21e-05 | 31 | 33 | 3 | CID000469669 | |
| Drug | 4,4'-thiodiphenol | 1.34e-05 | 32 | 33 | 3 | CID000017570 | |
| Drug | bromodeoxyuridine | 1.48e-05 | 376 | 33 | 6 | CID000006035 | |
| Drug | sulfisomidine | 2.03e-05 | 5 | 33 | 2 | CID000005343 | |
| Drug | tsuwabukinonol | 2.08e-05 | 37 | 33 | 3 | CID006440419 | |
| Drug | M50054 | 2.42e-05 | 117 | 33 | 4 | CID002748618 | |
| Drug | A805480 | 3.53e-05 | 44 | 33 | 3 | CID000620368 | |
| Drug | pirfenidone | 4.61e-05 | 138 | 33 | 4 | CID000040632 | |
| Drug | benzalkonium | 6.06e-05 | 148 | 33 | 4 | CID000007681 | |
| Drug | NSC34533 | 6.54e-05 | 54 | 33 | 3 | CID000003512 | |
| Drug | alitretinoin | 6.84e-05 | 301 | 33 | 5 | ctd:C103303 | |
| Drug | DIMIT | 7.30e-05 | 56 | 33 | 3 | CID000006624 | |
| Drug | CK 6 | 8.11e-05 | 58 | 33 | 3 | CID000447960 | |
| Drug | Calcein AM | 9.90e-05 | 62 | 33 | 3 | CID000390986 | |
| Drug | mebrofenin | 1.11e-04 | 11 | 33 | 2 | CID000054158 | |
| Drug | sulfosuccinimidobiotin | 1.33e-04 | 12 | 33 | 2 | CID000083894 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 187 | 33 | 4 | 4989_DN | |
| Drug | closantel | 1.57e-04 | 13 | 33 | 2 | CID000042574 | |
| Drug | K 2S | 1.57e-04 | 13 | 33 | 2 | CID000014800 | |
| Drug | 1 Pg | 1.57e-04 | 13 | 33 | 2 | CID000090255 | |
| Drug | 1pxm | 1.96e-04 | 78 | 33 | 3 | CID000447959 | |
| Drug | AC1L1F9Q | 1.97e-04 | 201 | 33 | 4 | CID000003144 | |
| Drug | moexipril | 2.41e-04 | 16 | 33 | 2 | CID000054889 | |
| Drug | AC1O517G | 2.41e-04 | 16 | 33 | 2 | CID006450188 | |
| Drug | JTV-519 | 3.07e-04 | 18 | 33 | 2 | CID000001715 | |
| Drug | potassiopotassium | 3.40e-04 | 94 | 33 | 3 | CID006432276 | |
| Drug | AC1L9LFK | 3.43e-04 | 19 | 33 | 2 | CID000447957 | |
| Drug | AC1L1GT5 | 3.51e-04 | 95 | 33 | 3 | CID000003829 | |
| Drug | dichloromethyl | 3.81e-04 | 20 | 33 | 2 | CID000123193 | |
| Drug | Ak 2 | 4.20e-04 | 21 | 33 | 2 | CID006475484 | |
| Drug | NSC339663 | 4.52e-04 | 250 | 33 | 4 | CID000003892 | |
| Drug | Lh 1 | 4.62e-04 | 22 | 33 | 2 | CID000191841 | |
| Drug | fluoropyruvate | 5.06e-04 | 23 | 33 | 2 | CID000067946 | |
| Drug | phorbol 12-myristate | 5.32e-04 | 261 | 33 | 4 | CID000107854 | |
| Drug | 3-MP | 5.51e-04 | 24 | 33 | 2 | CID000007970 | |
| Drug | h EIT | 5.99e-04 | 25 | 33 | 2 | CID000452078 | |
| Drug | 3',4'-dideoxykanamycin B | 5.99e-04 | 25 | 33 | 2 | CID000003021 | |
| Drug | methazolamide | 6.48e-04 | 26 | 33 | 2 | CID000004100 | |
| Drug | AC1L9H5I | 6.99e-04 | 27 | 33 | 2 | CID000444945 | |
| Drug | C15873 | 6.99e-04 | 27 | 33 | 2 | CID000045749 | |
| Drug | Arsenates | 7.28e-04 | 122 | 33 | 3 | ctd:D001149 | |
| Drug | 4-picoline | 7.52e-04 | 28 | 33 | 2 | CID000007963 | |
| Drug | 13,14-dihydro-15-ketoprostaglandin E2 | 7.81e-04 | 125 | 33 | 3 | CID004307039 | |
| Drug | 1-Aminoethyl)boronic acid | 8.07e-04 | 29 | 33 | 2 | CID000195309 | |
| Drug | AC1NQZM2 | 8.07e-04 | 29 | 33 | 2 | CID005282177 | |
| Drug | ENNG | 9.23e-04 | 31 | 33 | 2 | ctd:C013525 | |
| Drug | GW0742 | 9.23e-04 | 31 | 33 | 2 | ctd:C479979 | |
| Disease | Keratoderma, Palmoplantar | 1.57e-09 | 16 | 30 | 4 | C4551675 | |
| Disease | Pachyonychia Congenita | 9.47e-09 | 5 | 30 | 3 | C0265334 | |
| Disease | Epidermolytic ichthyosis | 9.99e-07 | 2 | 30 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 9.99e-07 | 2 | 30 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 9.99e-07 | 2 | 30 | 2 | cv:C1843463 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 9.99e-07 | 2 | 30 | 2 | C3665704 | |
| Disease | Keratosis of Greither | 9.99e-07 | 2 | 30 | 2 | C2936837 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 9.99e-07 | 2 | 30 | 2 | C1843463 | |
| Disease | Corneal Dystrophy, Juvenile Epithelial of Meesmann | 9.99e-07 | 2 | 30 | 2 | C0339277 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 9.99e-07 | 2 | 30 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 9.99e-07 | 2 | 30 | 2 | EFO_0021839 | |
| Disease | Palmoplantar keratoderma, epidermolytic | 9.99e-07 | 2 | 30 | 2 | cv:C1721006 | |
| Disease | Meesmann corneal dystrophy | 9.99e-07 | 2 | 30 | 2 | cv:C0339277 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 3.00e-06 | 3 | 30 | 2 | C1721006 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 3.00e-06 | 3 | 30 | 2 | C2931735 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 3.00e-06 | 3 | 30 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 3.00e-06 | 3 | 30 | 2 | C0343110 | |
| Disease | Pachyonychia congenita syndrome | 5.99e-06 | 4 | 30 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 5.99e-06 | 4 | 30 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 5.99e-06 | 4 | 30 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 5.99e-06 | 4 | 30 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 7.48e-06 | 124 | 30 | 4 | C0007137 | |
| Disease | Hyperkeratosis, Epidermolytic | 9.97e-06 | 5 | 30 | 2 | C0079153 | |
| Disease | Skin Neoplasms | 2.97e-05 | 59 | 30 | 3 | C0037286 | |
| Disease | Malignant neoplasm of skin | 2.97e-05 | 59 | 30 | 3 | C0007114 | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.69e-04 | 19 | 30 | 2 | C0349639 | |
| Disease | sphingomyelin measurement | 1.74e-04 | 278 | 30 | 4 | EFO_0010118 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 8.79e-04 | 43 | 30 | 2 | EFO_0004471, EFO_0006896 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSSGGDEGYGTGGGG | 181 | Q6ZN18 | |
| GLGTGGYSYITGGGG | 381 | Q6Y288 | |
| KRLSSGFGGGGGGGS | 26 | Q92625 | |
| SYGGGFGGGRGVGSG | 101 | Q01546 | |
| FGGVSGSGSGGYKGG | 526 | Q01546 | |
| QTSGGSGYKSGGGGS | 606 | Q01546 | |
| GGGYGGASGMGGITA | 51 | P05787 | |
| GGHGSSRGFGGGGYG | 626 | O00571 | |
| GYGGASGVGSGLGLG | 496 | P48668 | |
| SGVGSGLGLGGGSSY | 501 | P48668 | |
| SGGYGGLGGFGGGSF | 71 | P13645 | |
| GSYGGIFGGGSFGGG | 96 | P13645 | |
| GGSGSSMAGGLGAGY | 71 | Q99456 | |
| GGGSRGFGGASGGGY | 91 | P35527 | |
| GKIGLGGRGGSGGSY | 471 | P35527 | |
| GRGSRGGSGGSYGGG | 486 | P35527 | |
| HGGGSGFGGESGGSY | 586 | P35527 | |
| ASGSGGGYGGGSGKS | 606 | P35527 | |
| GYGGASGVGSGLGLG | 496 | P02538 | |
| SGVGSGLGLGGGSSY | 501 | P02538 | |
| GSGGGGSISGGGYGS | 551 | P35908 | |
| GSISGGGYGSGGGSG | 556 | P35908 | |
| GGYGSGGGSGGRYGS | 561 | P35908 | |
| GGGSGGRYGSGGGSK | 566 | P35908 | |
| GRYGSGGGSKGGSIS | 571 | P35908 | |
| GGGSKGGSISGGGYG | 576 | P35908 | |
| GGSISGGGYGSGGGK | 581 | P35908 | |
| GGGYGSGGGKHSSGG | 586 | P35908 | |
| GYGSGGGGSSSVKGS | 611 | P35908 | |
| TSASAGGYGGGYGGG | 531 | P12035 | |
| SKLYQGGPGGGSGGG | 611 | P54652 | |
| TISGGGSRGGGGGGY | 511 | P04264 | |
| YGSGGGGGGHGSYGS | 566 | P04264 | |
| GYGGASGVGSGLGLG | 496 | P04259 | |
| SGVGSGLGLGGGSSY | 501 | P04259 | |
| GIGGGIGYGQEGSSG | 96 | Q07627 | |
| GIGGGIGYGQEGSSG | 86 | Q8IUG1 | |
| IGGGIGYGQEGSGGS | 41 | P0C5Y4 | |
| GIGGCGGGSGGSVKY | 76 | P23490 | |
| GGGSGGSVKYSGGGG | 81 | P23490 | |
| GSVKYSGGGGSSGGG | 86 | P23490 | |
| YGGVSSGGSSGGGSG | 161 | P23490 | |
| YPGAGGGSGGGSGSS | 141 | P23769 | |
| GTGGSGGGGFGAATF | 51 | Q8WUU5 | |
| GSKGGYGSCGGSKGG | 76 | Q6L8H1 | |
| KKSSGAGGGSGSGGS | 6 | P22681 | |
| GSTGGGGSGAGTYVI | 401 | P22670 | |
| GGGGGGGGKKDSITY | 21 | O15266 | |
| GGGGGGGGATYVFKM | 816 | Q9UM73 | |
| GASTGGSGGYGGSGA | 251 | Q8TDD2 | |
| SGSPYGGGYGSGGGS | 356 | P51991 | |
| TYGGGGSAAATGAGG | 56 | P31314 | |
| SYANGTGSSGGGPGG | 6 | Q96K80 | |
| VNGGAGGGGSYGSGG | 496 | Q7Z794 | |
| SGFGYGGGVGGGFSG | 96 | O95678 |